Calquence 100 mg film-coated tablets
D8220L00087
Phase 2 small_molecule active
Quick answer
Calquence 100 mg film-coated tablets for mantle cell lymphoma (MCL) is a Phase 2 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- mantle cell lymphoma (MCL)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active